APO RESEARCH · REPORT
Closed Drug Transfer Systems
Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
Product & engineering
Understand the product.
Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
Selected research
Industry Research
Closed Drug Transfer Systems Industry Research Report 2026
Market perspective
Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
North America is the largest Closed Drug Transfer Systems market with about 73% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are BD Medical, Inc, Equashield, LLC, ICU Medical, Inc, Teva Medical Ltd, Corvida Medical etc. Top 3 companies occupied about 74% market share.
Report Scope
Read the full market overview
This report quantifies the global Closed Drug Transfer Systems market in terms of revenue (US$ million) and, where applicable, service volume (M Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Closed Drug Transfer Systems.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Closed Drug Transfer Systems Market by Company
BD Medical, Inc
Equashield, LLC
ICU Medical, Inc
Teva Medical Ltd
Corvida Medical
Closed Drug Transfer Systems Segment by Type
Closed Vial Access Devices
Closed Syringe Safety Devices
Closed Bag/Line Access Devices
Closed Drug Transfer Systems Segment by Application
Hospital
Clinic
Closed Drug Transfer Systems Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Closed Drug Transfer Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Closed Drug Transfer Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Closed Drug Transfer Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Closed Drug Transfer Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Closed Vial Access Devices
- Closed Syringe Safety Devices
- Closed Bag/Line Access Devices
Applications
- Hospital
- Clinic
Companies covered
- BD Medical, Inc
- Equashield, LLC
- ICU Medical, Inc
- Teva Medical Ltd
- Corvida Medical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Closed Drug Transfer Systems by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Closed Vial Access Devices
- 2.2.3 Closed Syringe Safety Devices
- 2.2.4 Closed Bag/Line Access Devices
- 2.3 Closed Drug Transfer Systems by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.4 Assumptions and Limitations
3 Closed Drug Transfer Systems Breakdown Data by Type
- 3.1 Global Closed Drug Transfer Systems Historic Market Size by Type (2021-2026)
- 3.2 Global Closed Drug Transfer Systems Forecasted Market Size by Type (2027-2032)
4 Closed Drug Transfer Systems Breakdown Data by Application
- 4.1 Global Closed Drug Transfer Systems Historic Market Size by Application (2021-2026)
- 4.2 Global Closed Drug Transfer Systems Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Closed Drug Transfer Systems Market Perspective (2021-2032)
- 5.2 Global Closed Drug Transfer Systems Growth Trends by Region
- 5.2.1 Global Closed Drug Transfer Systems Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Closed Drug Transfer Systems Historic Market Size by Region (2021-2026)
- 5.2.3 Closed Drug Transfer Systems Forecasted Market Size by Region (2027-2032)
- 5.3 Closed Drug Transfer Systems Market Dynamics
- 5.3.1 Closed Drug Transfer Systems Industry Trends
- 5.3.2 Closed Drug Transfer Systems Market Drivers
- 5.3.3 Closed Drug Transfer Systems Market Challenges
- 5.3.4 Closed Drug Transfer Systems Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Closed Drug Transfer Systems Players by Revenue
- 6.1.1 Global Top Closed Drug Transfer Systems Players by Revenue (2021-2026)
- 6.1.2 Global Closed Drug Transfer Systems Revenue Market Share by Players (2021-2026)
- 6.2 Global Closed Drug Transfer Systems Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Closed Drug Transfer Systems Head Office and Area Served
- 6.4 Global Closed Drug Transfer Systems Players, Product Type & Application
- 6.5 Global Closed Drug Transfer Systems Manufacturers Established Date
- 6.6 Global Closed Drug Transfer Systems Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Closed Drug Transfer Systems Market Size (2021-2032)
- 7.2 North America Closed Drug Transfer Systems Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Closed Drug Transfer Systems Market Size by Country (2021-2026)
- 7.4 North America Closed Drug Transfer Systems Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Closed Drug Transfer Systems Market Size (2021-2032)
- 8.2 Europe Closed Drug Transfer Systems Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Closed Drug Transfer Systems Market Size by Country (2021-2026)
- 8.4 Europe Closed Drug Transfer Systems Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Closed Drug Transfer Systems Market Size (2021-2032)
- 9.2 Asia-Pacific Closed Drug Transfer Systems Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Closed Drug Transfer Systems Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Closed Drug Transfer Systems Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Closed Drug Transfer Systems Market Size (2021-2032)
- 10.2 South America Closed Drug Transfer Systems Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Closed Drug Transfer Systems Market Size by Country (2021-2026)
- 10.4 South America Closed Drug Transfer Systems Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Closed Drug Transfer Systems Market Size (2021-2032)
- 11.2 Middle East & Africa Closed Drug Transfer Systems Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Closed Drug Transfer Systems Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Closed Drug Transfer Systems Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 BD Medical, Inc
- 12.1.1 BD Medical, Inc Company Information
- 12.1.2 BD Medical, Inc Business Overview
- 12.1.3 BD Medical, Inc Revenue in Closed Drug Transfer Systems Business (2021-2026)
- 12.1.4 BD Medical, Inc Closed Drug Transfer Systems Product Portfolio
- 12.1.5 BD Medical, Inc Recent Developments
- 12.2 Equashield, LLC
- 12.2.1 Equashield, LLC Company Information
- 12.2.2 Equashield, LLC Business Overview
- 12.2.3 Equashield, LLC Revenue in Closed Drug Transfer Systems Business (2021-2026)
- 12.2.4 Equashield, LLC Closed Drug Transfer Systems Product Portfolio
- 12.2.5 Equashield, LLC Recent Developments
- 12.3 ICU Medical, Inc
- 12.3.1 ICU Medical, Inc Company Information
- 12.3.2 ICU Medical, Inc Business Overview
- 12.3.3 ICU Medical, Inc Revenue in Closed Drug Transfer Systems Business (2021-2026)
- 12.3.4 ICU Medical, Inc Closed Drug Transfer Systems Product Portfolio
- 12.3.5 ICU Medical, Inc Recent Developments
- 12.4 Teva Medical Ltd
- 12.4.1 Teva Medical Ltd Company Information
- 12.4.2 Teva Medical Ltd Business Overview
- 12.4.3 Teva Medical Ltd Revenue in Closed Drug Transfer Systems Business (2021-2026)
- 12.4.4 Teva Medical Ltd Closed Drug Transfer Systems Product Portfolio
- 12.4.5 Teva Medical Ltd Recent Developments
- 12.5 Corvida Medical
- 12.5.1 Corvida Medical Company Information
- 12.5.2 Corvida Medical Business Overview
- 12.5.3 Corvida Medical Revenue in Closed Drug Transfer Systems Business (2021-2026)
- 12.5.4 Corvida Medical Closed Drug Transfer Systems Product Portfolio
- 12.5.5 Corvida Medical Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst